Cargando…
2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector
BACKGROUND: Point-of-care (POC) tuberculosis (TB) diagnostics may dramatically improve TB outcomes. Truenat is a new, battery-powered RT-PCR device that rapidly detects TB and rifampin resistance. Due to its portability, it may be valuable in peripheral healthcare settings. We evaluated the cost-eff...
Autores principales: | Lee, David J, Kumarasamy, Nagalingeswaran, Resch, Stephen, Sivaramakrishnan, Gomathi N, Mayer, Kenneth, Tripathy, Srikanth, Paltiel, A David, Freedberg, Kenneth, Reddy, Krishna P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254532/ http://dx.doi.org/10.1093/ofid/ofy210.1656 |
Ejemplares similares
-
Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector
por: Lee, David J., et al.
Publicado: (2019) -
The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India
por: Zheng, Amy, et al.
Publicado: (2018) -
A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays
por: Penn-Nicholson, Adam, et al.
Publicado: (2021) -
Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019
por: Basawarajappa, Shantala Gowdara, et al.
Publicado: (2021) -
Standardization & validation of Truenat™ point-of-care test for rapid diagnosis of Nipah
por: Yadav, Pragya D., et al.
Publicado: (2021)